Firefly Neuroscience Reports 20-Fold Commercial Footprint Expansion and 33-Fold Increase in EEG/ERP Scan Volumes

Reuters
03/04
<a href="https://laohu8.com/S/AIFF">Firefly Neuroscience</a> Reports 20-Fold Commercial Footprint Expansion and 33-Fold Increase in EEG/ERP Scan Volumes

Firefly Neuroscience Inc. reported a greater than 20-fold expansion of its commercial footprint and a 33-fold increase in EEG/ERP brain scan volumes. The company said that by the end of 2025 it had 99 commercial users who completed more than 10,800 EEG/ERP brain scans, following its acquisition of Evoke Neuroscience, Inc. Firefly also reported that partner sites and EEG/ERP clinical assessments increased 1,880% and 3,227%, respectively, compared with the end of 2024.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Firefly Neuroscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603040745PRIMZONEFULLFEED9665671) on March 04, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10